ACTB expression was observed higher in cervical cancer, head and neck cancer, leukemia, lymphoma and pancreatic cancer compared with normal tissues (Figure 2(a)), and lower in breast cancer, lung cancer, ovarian cancer and prostate cancer. This evidence concerns the gene ACTB and breast carcinoma.